The US national cholesterol education programme adult treatment panel III (NCEP ATP III):: prevalence of the metabolic syndrome in postmenopausal Latin American women

被引:79
作者
Royer, M. [1 ]
Castelo-Branco, C. [1 ]
Blumel, J. E. [1 ]
Chedraui, P. A. [1 ]
Danckers, L. [1 ]
Bencosme, A. [1 ]
Navarro, D. [1 ]
Vallejo, S. [1 ]
Espinoza, M. T. [1 ]
Gomez, G. [1 ]
Izaguirre, H. [1 ]
Ayala, F. [1 ]
Martino, M. [1 ]
Ojeda, E. [1 ]
Onatra, W. [1 ]
Saavedra, J. [1 ]
Tserotas, K. [1 ]
Pozzo, E. [1 ]
Manriquez, V. [1 ]
Prada, M. [1 ]
Grandia, E. [1 ]
Zuniga, C. [1 ]
Lange, D. [1 ]
Sayegh, F. [1 ]
机构
[1] Hosp Clin Barcelona, Inst Clin Ginecol Obstet & Neonatol, Barcelona 08036, Spain
关键词
metabolic syndrome; Latin America; obesity; blood pressure; cardiovascular disease; cholesterol; dysilipidemia; guidelines; hypertension; type 2 diabetes mellitus;
D O I
10.1080/13697130701258895
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Metabolic syndrome (METS) is a strong predictor of cardiovascular risk. Since the prevalence of METS increases after menopause, gynecological routine consultation offers an excellent screening opportunity. Objectives To assess the prevalence of METS in Latin American postmenopausal women and factors modifying its risk; as well as to assess the role of simple routine care measurements in the diagnosis of the METS. Methods A total of 3965 postmenopausal women, aged 45-64 years, seeking health care at 12 gynecological centers in major Latin American cities were included in this cross-sectional study. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guidelines were applied to assess METS. This was present if three or more of the following conditions were present: waist circumference >= 88 cm; blood pressure >= 130/85 mmHg; fasting plasma triglycerides >= 150 mg/dl; high density lipoprotein (HDL) cholesterol < 50 mg/dl; glucose >= 110 mg/dl or subjects were receiving treatment for their condition. Results The prevalences of having at least two, three, four or five components were 62.5, 35.1, 13.5 and 3.2%, respectively. The prevalence increased from 28.1% in those aged 40-44 years to 42.9% in those aged 60-64 years. The risk of METS detection (multivariate analysis) increased with age (odds ratio (OR) 1.22, 95% confidence interval (CI) 1.03-1.43), time elapsed since menopause (OR 1.18, 95% CI 1.00-1.38), smoking cigarettes (OR 1.40, 95% CI 1.19-1.65), obesity (OR 13.01, 95% CI 10.93-15.49) and hypertension (OR 9.30, 95% CI 7.91-10.94). In contrast, hormone therapy reduces this risk (OR 0.59, 95% CI 0.51-0.70). Conclusion There is a high prevalence of the metabolic syndrome in postmenopausal Latin American women seeking gynecologic health care. Age, years since menopause, obesity and hypertension are strong predictors of this condition.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 27 条
[1]   High prevalence of metabolic syndrome in Mexico [J].
Aguilar-Salinas, CA ;
Rojas, R ;
Gómez-Pérez, FJ ;
Valles, V ;
Ríos-Torres, JM ;
Franco, A ;
Olaiz, G ;
Rull, JA ;
Sepúlveda, J .
ARCHIVES OF MEDICAL RESEARCH, 2004, 35 (01) :76-81
[2]  
Al-Nozha MM, 2005, SAUDI MED J, V26, P1918
[3]  
[Anonymous], 2005, IDF CONS WORLDW DEF
[4]  
[Anonymous], 2020, WHONCDNCS992
[5]   The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study [J].
Athyros, VG ;
Bouloukos, VI ;
Pehlivanidis, AN ;
Papageorgiou, AA ;
Dionysopoulou, SG ;
Symeonidis, AN ;
Petridis, DI ;
Kapousouzi, MI ;
Satsoglou, EA ;
Mikhailidis, DP .
DIABETES OBESITY & METABOLISM, 2005, 7 (04) :397-405
[6]   Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study [J].
Azizi, F ;
Salehi, P ;
Etemadi, A ;
Zahedi-Asl, S .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :29-37
[7]  
Brett K.M., 2001, HORMONE REPLACEMENT
[8]   The emergence of the metabolic syndrome with menopause [J].
Carr, MC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2404-2411
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359